Body-first versus brain-first biological subtyping of Parkinson’s disease is a research paper published in Brain (2020). On theSindex it has a DataRank of 0. It has been cited 30 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
NINDS NIH HHS
Grant: P50 NS091856
RRD VA
Grant: I01 RX001631
Canadian Institutes of Health Research
Grant: unidentified
unidentified
Department of Veterans Affairs
Fonds de la Recherche en Sante Quebec
Novartis, Roche, Takeda, and Theranexus and speaker fees fromBoehringer-Ingelhaim, Novartis Canada
Abbvie, Biotie, GE Health Care, Janssen, Jazz Pharmaceuticals
NIH
Otsuka Pharmaceuticals and Teva Neurosciences
Webster Foundation
Weston-Garfield Foundation
Canadian Institute of Health Research
Michael J. Fox Foundation
Eisai, EIP Pharma
Expansion Therapeutics and Innovative Health Solutions
the Parkinson Society
National Institute of Health
Canadian Institute of Health Research
FWCI
0.92
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals